Free Trial

Regencell Bioscience (RGC) Stock Price, News & Analysis

Regencell Bioscience logo
$13.42 -0.02 (-0.15%)
As of 04:00 PM Eastern

About Regencell Bioscience Stock (NASDAQ:RGC)

Key Stats

Today's Range
$13.30
$13.74
50-Day Range
$10.36
$63.35
52-Week Range
$0.09
$83.60
Volume
337,656 shs
Average Volume
572,658 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Regencell Bioscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

RGC MarketRank™: 

Regencell Bioscience scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Regencell Bioscience.

  • Price to Book Value per Share Ratio

    Regencell Bioscience has a P/B Ratio of 671.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    9.57% of the float of Regencell Bioscience has been sold short.
  • Short Interest Ratio / Days to Cover

    Regencell Bioscience has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Regencell Bioscience has recently increased by 47.97%, indicating that investor sentiment is decreasing significantly.
  • Percentage of Shares Shorted

    9.57% of the float of Regencell Bioscience has been sold short.
  • Short Interest Ratio / Days to Cover

    Regencell Bioscience has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Regencell Bioscience has recently increased by 47.97%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Regencell Bioscience has a news sentiment score of 1.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.48 average news sentiment score of Manufacturing companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Regencell Bioscience this week, compared to 3 articles on an average week.
  • Search Interest

    Only 21 people have searched for RGC on MarketBeat in the last 30 days. This is a decrease of -55% compared to the previous 30 days.
  • MarketBeat Follows

    Only 14 people have added Regencell Bioscience to their MarketBeat watchlist in the last 30 days. This is a decrease of -7% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Regencell Bioscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.00% of the stock of Regencell Bioscience is held by insiders.

  • Percentage Held by Institutions

    Only 0.13% of the stock of Regencell Bioscience is held by institutions.

  • Read more about Regencell Bioscience's insider trading history.
Receive RGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Regencell Bioscience and its competitors with MarketBeat's FREE daily newsletter.

RGC Stock News Headlines

RGC Resources: The Impact Of MVP
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.
See More Headlines

RGC Stock Analysis - Frequently Asked Questions

Regencell Bioscience's stock was trading at $63.35 at the beginning of the year. Since then, RGC shares have decreased by 78.8% and is now trading at $13.42.

Shares of Regencell Bioscience split before market open on Monday, June 16th 2025.The 38-1 split was announced on Monday, June 2nd 2025. The newly issued shares were payable to shareholders after the market closes on Sunday, June 15th 2025. An investor that had 100 shares of stock prior to the split would have 3,800 shares after the split.

Regencell Bioscience (RGC) raised $22 million in an IPO on Friday, July 16th 2021. The company issued 2,300,000 shares at $8.50-$10.50 per share.

Top institutional investors of Regencell Bioscience include Geode Capital Management LLC, Y Intercept Hong Kong Ltd and Greenfield Savings Bank.

Shares of RGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/13/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medicinal Chemicals
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RGC
Previous Symbol
NASDAQ:RGC
CIK
1829667
Web
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.02 per share
Price / Book
667.50

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
N/A
Beta
2.20
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:RGC) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners